The weekly litigation news digest is live. Subscribe now

Composition Comprising Epa And Dha For An Enhanced Efficacy Of Anticancer Agents

Patent No. EP3525781 (titled "Composition Comprising Epa And Dha For An Enhanced Efficacy Of Anticancer Agents") was filed by Fresenius Kabi Deutschland on Oct 5, 2017. The application was issued on Apr 24, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
NUTRICIAOct 27, 2021VO

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3525781

FRESENIUS KABI DEUTSCHLAND
Application Number
EP17780718A
Filing Date
Oct 5, 2017
Status
Patent Maintained As Amended
Mar 22, 2024
Publication Date
Apr 24, 2024